Delivery Order SPE2DB22D3011-SPE2DB25FQ1LL
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The contract has a ceiling value of $61,017.59 and a period of performance through October 6, 2023. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $16,328.26 and a completion date of May 28, 2025. The contract is a firm fixed-price delivery order and is not a set-aside. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENBREL 50 MG/ML syringes, with a ceiling value of $46,145.13 and a performance period through January 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENBREL 25 MG/0.5 ML syringes, a specialty pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $6,067.06, and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of ENBREL 50 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a total ceiling value of $33,053.16 and a period of performance through September 6, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, will be the prime contractor responsible for delivering...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the supply of ENBREL 50 MG/ML SYRINGE, a pharmaceutical product, with a firm fixed price of $14,479.69 and a period of performance through July 16, 2025. The contract is not set aside and was awarded on an open competitive basis. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a specialty medication, to support federal healthcare programs. The contract has a ceiling value of $88,817.42 and a completion date of January 19, 2023. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 25 MG/0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $39,979.14 and a period of performance through March 4, 2025. It is a firm fixed-price delivery order contract. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $27,475.98 and a period of performance ending on July 14, 2025. The contract is not set aside and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The contract has a firm fixed price of $63,147.30 and a completion date of January 21, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ1LLDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ENBREL 50 MG/ML SYRINGE medication. The contract has a ceiling value of $38,962.19 and is a firm fixed-price delivery order, with a period of performance ending on June 26, 2025. The contract is not designated as a set-aside and was open to full and open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is associated with the company's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.0k | 6/25/25 |